Veterinary Medicine Information website

Parvoruvax suspension injectable

Authorised
  • Porcine parvovirus, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Download as PDF

Product identification

Medicine name:
Parvoruvax suspension injectable
Active substance:
  • Porcine parvovirus, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Porcine parvovirus, Inactivated
    2.00
    millilitre(s)
    /
    1.00
    Dose
  • Erysipelothrix rhusiopathiae, serotype 2, Inactivated
    1.00
    enzyme-linked immunosorbent assay unit/dose
    /
    1.00
    dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • All relevant tissues
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Luxembourg
Package description:
  • Parvoruvax 1 Vial with 25 doses (50 ml) of Suspension for injection
  • Parvoruvax 1 Vial with 5 doses (10 ml) of Suspension for injection
  • Parvoruvax 1 Vial with 50 doses (100 ml) of Suspension for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Zrt.
Responsible authority:
  • Ministry Of Health And Social Security
Authorisation number:
  • V 915/89/07/0274
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 24/07/2024
Download